SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-020286
Filing Date
2024-03-06
Accepted
2024-03-06 08:00:20
Documents
6
Period of Report
2024-03-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0201196-6k_aptorum.htm 6-K 81442
2 MERGER AGREEMENT BY AND BETWEEN APTORUM AND YOOV, DATED MARCH 1, 2024 ea0201196ex2-1_aptorum.htm EX-2.1 498758
3 SPLIT-OFF AGREEMENT BY AND BETWEEN APTORUM, ATL AND JURCHEN, DATED MARCH 1, 2024 ea0201196ex10-1_aptorum.htm EX-10.1 119481
4 SUPPORT AGREEMENT BY AND BETWEEN APTORUM AND ITS MAJOR SHAREHOLDER, DATED MARCH ea0201196ex10-2_aptorum.htm EX-10.2 53608
5 FORM OF LOCK-UP AGREEMENT ea0201196ex10-3_aptorum.htm EX-10.3 36221
6 PRESS RELEASE ea0201196ex99-1_aptorum.htm EX-99.1 23967
  Complete submission text file 0001213900-24-020286.txt   814487
Mailing Address 17 HANOVER SQUARE LONDON X0 W1S 1BN
Business Address 17 HANOVER SQUARE LONDON X0 W1S 1BN 852 3953 7700
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38764 | Film No.: 24724395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)